Elanco Animal Health Inc $ 30 -0.61 (-1.99%)
Volume:
4,777,171
Avg Vol (1m):
4,518,588
Market Cap $:
11.19 Bil
Enterprise Value $:
13.24 Bil
P/E (TTM):
115.38
P/B:
2.04
Financial Strength |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.13 | ||
| Equity-to-Asset | 0.62 | ||
| Debt-to-Equity | 0.43 | ||
| Debt-to-EBITDA | 5.06 | ||
| Interest Coverage | 4.78 | ||
| Altman Z-Score | 2.65 | ||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 12.59 | ||
| Net Margin % | 3.04 | ||
| ROE % | 1.78 | ||
| ROA % | 1.05 | ||
| ROC (Joel Greenblatt) % | 7.81 | ||
| 3-Year Revenue Growth Rate | 6.2 | ||
| 3-Year EBITDA Growth Rate | 27.3 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 115.38 | ||
| Forward PE Ratio | 24.75 | ||
| PE Ratio without NRI | 115.38 | ||
| PB Ratio | 2.04 | ||
| PS Ratio | 3.58 | ||
| Price-to-Free-Cash-Flow | 121.46 | ||
| Price-to-Operating-Cash-Flow | 46.58 | ||
| EV-to-EBIT | 81.99 | ||
| EV-to-EBITDA | 28.4 | ||
| EV-to-Revenue | 4.29 | ||
| Current Ratio | 3.12 | ||
| Quick Ratio | 1.67 | ||
| Days Inventory | 256.28 | ||
| Days Sales Outstanding | 89.77 | ||
| Days Payable | 51.08 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 103.45 | ||
| Price-to-Median-PS-Value | 1.01 | ||
| Price-to-Graham-Number | 23.26 | ||
| Earnings Yield (Greenblatt) % | 1.22 |